Events /// Investor News /// Investment Case /// Resources
Bayer is committed to providing sustainable solutions that address humanity’s most fundamental needs for essential healthcare and nutritious food. The Bayer Investor Relations Team is dedicated to creating transparency, fostering dialogue, and delivering value to our stakeholders.
Upcoming Events and Highlights
Investor News
Share Price / Index
March 26, 2025
Not intended for U.S. and UK Media
Bayer and Puhe BioPharma enter into global license agreement for clinical phase I PRMT5 inhibitor
March 17, 2025
Not intended for U.S. and UK Media
U.S. FDA grants Priority Review for new indication of finerenone for patients with common form of heart failure
March 05, 2025
Financial News Conference:
Bayer meets adjusted guidance and takes decisive action to tackle challenges
Discover More
